This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1972 Apr;191(4):343-7.

Plasma turnover of methyldopa in advanced renal failure

E Myhre, E K Brodwall, O Stenbaek, T Hansen

PMID: 5032679

Plasma turnover of methyldopa in advanced renal failure

E Myhre et al. Acta Med Scand. 1972 Apr.

. 1972 Apr;191(4):343-7.

Authors

E Myhre, E K Brodwall, O Stenbaek, T Hansen

PMID: 5032679

No abstract available

PubMed Disclaimer

Similar articles

The effect of methyldopa on renal function in patients with renal insufficiency.
Brodwall EK, Myhre E, Stenbaek O, Hansen T. Brodwall EK, et al. Acta Med Scand. 1972 Apr;191(4):339-41. Acta Med Scand. 1972. PMID: 5032678 No abstract available.
Glomerular filtration rate measurement in cirrhotic patients with renal failure.
Roy L, Legault L, Pomier-Layrargues G. Roy L, et al. Clin Nephrol. 1998 Dec;50(6):342-6. Clin Nephrol. 1998. PMID: 9877106
The renal excretion of methyldopa.
Myhre E, Brodwall EK, Stenbaek O, Hansen T. Myhre E, et al. Scand J Clin Lab Invest. 1972 Apr;29(2):201-4. doi: 10.3109/00365517209081076. Scand J Clin Lab Invest. 1972. PMID: 5029324 No abstract available.
[Markers of chronic renal failure and assessment of renal function].
Papaian AV, Arkhipov Vv, Beresneva EA. Papaian AV, et al. Ter Arkh. 2004;76(4):83-90. Ter Arkh. 2004. PMID: 15174331 Review. Russian. No abstract available.
[Glomerular filtration markers in pediatrics].
Prévot A, Martini S, Guignard JP. Prévot A, et al. Rev Med Suisse Romande. 2002 Dec;122(12):625-30. Rev Med Suisse Romande. 2002. PMID: 12611189 Review. French.

See all similar articles

Cited by

Pharmacokinetics of methyldopa in healthy man.
Stenbaek O, Myhre E, Rugstad HE, Arnold E, Hansen T. Stenbaek O, et al. Eur J Clin Pharmacol. 1977 Oct 14;12(2):117-23. doi: 10.1007/BF00645132. Eur J Clin Pharmacol. 1977. PMID: 923625 No abstract available.
Comparative bioavailability of alpha-methyldopa normal and film tablet formulations after single oral administration in healthy volunteers.
Róna K, Ary K, Renczes G, Gachályi B, Grézal GY, Drabant S, Klebovich I. Róna K, et al. Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):25-30. doi: 10.1007/BF03190372. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11554430
Clinical pharmacokinetics of methyldopa.
Myhre E, Rugstad HE, Hansen T. Myhre E, et al. Clin Pharmacokinet. 1982 May-Jun;7(3):221-33. doi: 10.2165/00003088-198207030-00003. Clin Pharmacokinet. 1982. PMID: 7047042 Review.
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Wollam GL, Gifford RW Jr, Tarazi RC. Wollam GL, et al. Drugs. 1977 Dec;14(6):420-60. doi: 10.2165/00003495-197714060-00002. Drugs. 1977. PMID: 23284 Review. No abstract available.
The pharmacokinetics of alpha-methyldopa in dogs.
Kochak GM, Mason WD. Kochak GM, et al. J Pharmacokinet Biopharm. 1985 Aug;13(4):405-23. doi: 10.1007/BF01061477. J Pharmacokinet Biopharm. 1985. PMID: 3841366

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley